Current Issue
The Infectious Resistance of Antiviral Innate Immunity (2022)
Short Communication
Pages: 1 - 2SARS-CoV-2 and its Focus on Antiviral Therapy
DOI: 10.35284/2471-5964.22.S25.004
Short Communication
Pages: 1 - 2The Analysis of Human Acquired Immunodeficiency Syndrome
DOI: 10.35284/2471-5964.22.S25.001
Perspective
Pages: 0 - 1Rare Coinfection of Genital Herpes and Pneumococcal Meningitis
DOI: 10.35248/1948-5964.22.S25.003
Opinion
Pages: 1 - 2Vaccines and Fibroblast Intracellular Resistant Developments
DOI: 10.35248/1948-5964.22.S25.005
Commentary
Pages: 0 - 1Symptoms and Diagnostic Procedures for Chronic Hepatitis
DOI: 10.35248/1948-5964.22.S25.002
Volume 15, Issue 3 (2023)
Perspective
Pages: 1 - 1The Role of MAIT Cells in Immunogenicity of Viral Vector Vaccinations
DOI: 10.35248/1948-5964.23.15.267
Commentary
Pages: 1 - 1Advancements of Antiretrovirals: Milestone in the Fight against HIV/AIDS
DOI: 10.35248/1948-5964.23.15.268
Perspective
Pages: 1 - 1The Persistent Threat of Zoonotic Viruses to Global Health
DOI: 10.35248/1948-5964.23.15.269
Commentary
Pages: 1 - 1Unveiling the Complicated Activity at the Virus-Host Interface: Insights and Implications
DOI: 10.35248/1948-5964.23.15.270
Opinion Article
Pages: 1 - 1Unleashing the Potential of Protease Inhibitors in Therapeutic Interventions
DOI: 10.35248/1948-5964.23.15.271
Perspective
Pages: 1 - 1Pathophysiology of an Antiviral Agent for the Treatment of Respiratory Infections
DOI: 10.35248/1948-5964.23.15.272
Perspective
Pages: 1 - 1Significance of Oseltamivir the First Line Drug of Influenza
DOI: 10.35248/1948-5964.23.15.273
Short Communication
Pages: 1 - 2Exploratory Variations of Entry Inhibitors and their use in the Treatment of Infections Diseases
DOI: 10.35248/1948-5964.23.15.275
Commentary
Pages: 1 - 2The Rhinovirus: Understanding the Common Colds antigen and Its Impact on Human Health
DOI: 10.35248/1948-5964.23.15.276
Opinion Article
Pages: 1 - 1Understanding the Complexity of Viral Evolution Using the Quasispecies Model
DOI: 10.35248/1948-5964.23.15.274
Volume 17, Issue 1 (2025)
Commentary
Pages: 1 - 1Broad-Spectrum Antiviral Agents in the Fight against Emerging Viruses
DOI: 10.35248/2572-0805-25.17.340
Commentary
Pages: 1 - 1Next-Generation Antiretrovirals Long-Acting Formulations and Injectable Therapies
DOI: 10.35248/2572-0805-25.17.342
Opinion
Pages: 1 - 1Antiviral Nanotechnology A New Frontier in Viral Infection Management
DOI: 10.35248/2572-0805-25.17.343
Opinion Article
Pages: 1 - 2Targeting Viral Replication: Advances in Polymerase and Protease Inhibitors
DOI: 10.35248/2572-0805-25.17.344
Commentary
Pages: 1 - 2Mechanisms of Drug Resistance in Antiretroviral Therapy Clinical Implications
DOI: 10.35248/2572-0805-25.17.341
Perspective
Pages: 1 - 2Role of Host-Directed Therapies in Enhancing Antiviral Efficacy
DOI: 10.35248/2572-0805-25.17.345
Perspective
Pages: 1 - 2Combination Antiviral Strategies for Drug-Resistant Viral Infections
DOI: 10.35248/2572-0805-25.17.346
Perspective
Pages: 1 - 2Pharmacokinetics and Safety Profiles of Novel Antiretroviral Agents
DOI: 10.35248/2572-0805-25.17.347
Commentary
Pages: 1 - 2Antiviral Drug Development in the Age of Pandemic Preparedness
DOI: 10.35248/2572-0805-25.17.348
Short Communication
Pages: 1 - 2Optimizing Pediatric Antiretroviral Therapy Dosing Adherence and Outcomes
DOI: 10.35248/2572-0805-25.17.349
Volume 15, Issue 4 (2023)
Opinion Article
Pages: 1 - 2Therapeutic Potential: Exploring Natural Compounds as Antiviral Agent against Viral Infections
DOI: 10.35248/1948-5964.23.15.283
Opinion Article
Pages: 1 - 2Paediatric Antiretroviral Therapy: Enhancing Treatment to Improve Adherence and Outcomes
DOI: 10.35248/1948-5964.23.15.284
Perspective
Pages: 1 - 2Next-Generation Antiviral Therapies: Integrating Computational Design and In Vitro Evaluations
DOI: 10.35248/1948-5964.23.15.285
Commentary
Pages: 1 - 2The Ethical Implications of Antiviral and Antiretroviral Accessibility: A Global Health Perspective
DOI: 10.35248/1948-5964.23.15.286
Commentary
Pages: 1 - 2New Frontiers in Antiviral Therapy: Targeting Emerging and Re-Emerging Viruses
DOI: 10.35248/1948-5964.23.15.277
Perspective
Pages: 1 - 2Advancements in Antiretroviral Treatments: An Overview on the Latest Drugs
DOI: 10.35248/1948-5964.23.15.278
Opinion Article
Pages: 1 - 2Combination Strategies in Antiretroviral Therapy: Improving Outcomes for HIV/AIDS Patients
DOI: 10.35248/1948-5964.23.15.279
Opinion Article
Pages: 1 - 2Innovative Nanoformulations in Antiretroviral Delivery: Enhancing Bioavailability and Reducing Toxicity
DOI: 10.35248/1948-5964.23.15.281
Opinion Article
Pages: 1 - 2The Impact of COVID-19 Variants on Antiviral Drug Efficacy
DOI: 10.35248/1948-5964.23.15.280
Opinion Article
Pages: 1 - 2Resistance Mechanisms in Chronic Viral Infections and Devising Strategies to Overcome Antiviral Resistance
DOI: 10.35248/1948-5964.23.15.282
Insight to Antiviral Research (2021)
Research Article
Pages: 1 - 4The Effects of COVID-19 on Spermatogenesis
Mostafa Kamel, Ahmed Abde Moniem, Mohammed Zarzour, Ade Kurkar and Hosny Behnsawy*
DOI: 10.35248/1948-5964.21.s22.002
Review Article
Pages: 1 - 5Role of Pulmonary Surfactant in Gas Exchange Mechanism and Providing Protection against Progression of any Respiratory Viral Disease like SARS-CoV-2 and Need to focus it as First Point of Medication for all Respiratory Diseases
DOI: 10.35248/1948-5964.21.s22.005
Editorial
Pages: 1 - 1Crimean Congo Hemorrhagic Fever Insights
DOI: 10.35248/1948-5964.21.s22.e004
Editorial Note
Pages: 1 - 1Antiviral Drug Discovery
DOI: 10.35248/1948-5964.21.s22.e003
Research Article
Pages: 1 - 6United States Ending the Human Immunodeficiency Virus (HIV) Epidemic Plan: Evaluation of the Role of Industry Funding in Published Pre-Exposure Prophylaxis (PrEP) Literature
Somya Gupta*, Salman Khan, Rinsa Vaheed and Reuben Granich
DOI: 10.35248/1948-5964.21.s22.001